Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 9, Number 6—June 2003

Dispatch

Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi

Stephen B. Gordon*Comments to Author , Stonard Kanyanda*, Amanda L. Walsh*, Kristy Goddard*, Mas Chaponda†, Victoria Atkinson†, Wakisa Mulwafu†, Elizabeth M. Molyneux†, Ed E. Zijlstra†, Malcolm E. Molyneux*, and Steve M. Graham*
Author affiliations: *Wellcome Trust Research Laboratories, University of Malawi, Liverpool, U.K.; †University of Malawi College of Medicine, Blantyre, Malawi

Main Article

Figure

The cumulative percentage of all pneumococcal isolates plotted by source (see key). Serogroups covered by the 7-valent vaccine are plotted to the left of the heavy vertical line, and the potential 9-valent coverage is illustrated by the dotted vertical line.

Figure. The cumulative percentage of all pneumococcal isolates plotted by source (see key). Serogroups covered by the 7-valent vaccine are plotted to the left of the heavy vertical line, and the potential 9-valent coverage is illustrated by the dotted vertical line.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO